From: Reframing gene essentiality in terms of adaptive flexibility
Keio | Exp. # | Fraction | Gene | Protein change | Perceived impact |
---|---|---|---|---|---|
strain | Â | population | Â | Â | Â |
Δ thrA | 4 | 0.58 | metK | N226S | - |
 | 2 | 0.46 | metK | G235A | - |
 | 2 | 0.23 | metJ | V46E | *Reduce MetJ repression1 |
 | 1 | 0.79 | metJ/metB | Intergenic (-211/-66) | *Reduce MetJ repression1 |
 | 3 | - | 117 genes | 130 kbp, 1.2X GDA | Increase metL expression |
 |  |  | [rrlA-rrfB] |  |  |
Δ ptsI | 4, 5 | 1.0, 0.82 | ydhF | G65S | - |
 | (1, 4, | (1.0, 1.0, | metK/galP | Intergenic (+328/-96) | *Reduce GalR repression2 |
 | 5, 6) | 0.36, 0.39) |  |  |  |
 | 5 | 0.25 | metK/galP | Intergenic (+333/-91) | Reduce GalR repression2 |
 | 3 | 1.0 | metK/galP | Intergenic (+334/-90) | Reduce GalR repression2 |
 | 6 | 0.57 | metK/galP | Intergenic (+339/-85) | Reduce GalR repression2 |
 | 3 | 1.0 | crp | T141P | Global regulatory effects3 |
 | 5 | 0.70 | crp | G142S | Global regulatory effects3 |
 | 6 | 0.59 | crp | G142D | Global regulatory effects3 |
 | 4 | 1.0 | crp | R143H | Global regulatory effects3 |
 | 1 | 1.0 | crp | A145V | Global regulatory effects3 |
 | 6 | 0.43 | crp | I187T | Global regulatory effects3 |
 | 7 | 1.0 | 96 genes | 99 kbp, 2X GDA | Affect cyaA expression |
 |  |  | [rrsC-rrlA] |  |  |
Δ serB | 1 | 0.67 | hisL/hisG | Intergenic (+41/-105) | *Increase his operon expression4 |
 | 5 | 0.43 | yhaC/garK | Intergenic (+653/+370) | - |
 | 1 | 0.27 | yhaC/garK | Intergenic (+883/+140) | - |
 | 6 | 0.88 | hisR | His tRNA (5/77 bp) | Increase his operon expression4 |
 | 2 | 0.82 | hisR | His tRNA (48/77 bp) | Increase his operon expression4 |
 | 4 | 0.92 | hisR | His tRNA (67/77 bp) | *Increase his operon expression4 |
 | 7 | 0.71 | hisR | His tRNA (72/77 bp) | Increase his operon expression4 |
Δ proA | 2 | 1.0 | proB | 1 bp Del | - |
 | 1 | 0.77 | argD | G282D | Reduce ArgD activity |
 | 2 | 0.56 | argD | Del (772-774/1221 bp) | Reduce ArgD activity |
 | 4 | 0.43 | argD | Q154* | Reduce ArgD activity |
 | 3 | 0.34 | argD | G49R | Reduce ArgD activity |
Δ proB | 6, 7 | 0.83, 0.72 | glnA | F463L | Reduce GlnA activity |
 | 5 | 0.86 | glnA | D187E | Reduce GlnA activity |
 | 4 | 0.45 | glnA | G179C | Reduce GlnA activity |
 | 4 | 0.23 | glnA | H172R | Reduce GlnA activity |
 | 1 | 1.0 | glnA | G171S | Reduce GlnA activity |
 | 2 | 0.86 | glnA | E156D | Reduce GlnA activity |
 | 3 | 1.0 | glnA | S148F | Reduce GlnA activity |
Δ carA | 7 | 0.27 | carA/ carB | Intergenic (+2/-16) | Increase carB expression |
 | 5 | 0.86 | carB | L11L | - |
 | 3, 7 | 0.31, 0.81 | rpoS | E96* | - |
 | 3, 7 | 1.0 | 508 genes | 520 kbp, 2X GDA | Increase carB expression |
 |  |  | [insD6-insD1] |  |  |
Δ metC | 4 | 0.55 | malI | 10bp Dup (227/1029 bp) | Reduce MalI activity5 |
 | 2 | 0.32 | malI | Q55* | Reduce MalI activity5 |
 | 3 | 0.55 | malX | Q529Q | - |
Δ metL | 2, 4 | 0.72, 0.38 | rpoS | L317R | - |
 | 4 | 1.0 | metB | 1 bp Del (1144/1161 bp) | - |
Δ cysK | 1 | 1.0 | 2,062 genes | 2.1 Mbp, 2X GDA | Increase cysM expression |
 |  |  | [insL3-insL1] |  |  |
 | 3 | 0.21 | sspA/rpsI | Intergenic (-10/+385) | - |